Source:http://linkedlifedata.com/resource/pubmed/id/17138741
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2006-12-1
|
pubmed:abstractText |
The lungs are the most frequent sites of distant metastasis in differentiated thyroid carcinoma. Radioiodine treatment planning for these patients is usually performed following the Benua-Leeper method, which constrains the administered activity to 2.96 GBq (80 mCi) whole-body retention at 48 h after administration to prevent lung toxicity in the presence of iodine-avid lung metastases. This limit was derived from clinical experience, and a dosimetric analysis of lung and tumor absorbed dose would be useful to understand the implications of this limit on toxicity and tumor control. Because of highly nonuniform lung density and composition as well as the nonuniform activity distribution when the lungs contain tumor nodules, Monte Carlo dosimetry is required to estimate tumor and normal lung absorbed dose. Reassessment of this toxicity limit is also appropriate in light of the contemporary use of recombinant thyrotropin (thyroid-stimulating hormone) (rTSH) to prepare patients for radioiodine therapy. In this work we demonstrated the use of MCNP, a Monte Carlo electron and photon transport code, in a 3-dimensional (3D) imaging-based absorbed dose calculation for tumor and normal lungs.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0161-5505
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1985-94
|
pubmed:dateRevised |
2011-3-11
|
pubmed:meshHeading |
pubmed-meshheading:17138741-Algorithms,
pubmed-meshheading:17138741-Body Burden,
pubmed-meshheading:17138741-Humans,
pubmed-meshheading:17138741-Iodine Radioisotopes,
pubmed-meshheading:17138741-Lung Neoplasms,
pubmed-meshheading:17138741-Organ Specificity,
pubmed-meshheading:17138741-Radiometry,
pubmed-meshheading:17138741-Radiopharmaceuticals,
pubmed-meshheading:17138741-Radiotherapy Dosage,
pubmed-meshheading:17138741-Radiotherapy Planning, Computer-Assisted,
pubmed-meshheading:17138741-Relative Biological Effectiveness,
pubmed-meshheading:17138741-Thyroid Neoplasms
|
pubmed:year |
2006
|
pubmed:articleTitle |
Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
|
pubmed:affiliation |
Division of Nuclear Medicine, Russell H Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, MD 21231, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, N.I.H., Extramural
|